GENES.annotation_type	gene
GENES.assembly	hg19
GENES.contact	gencode@sanger.ac.uk
GENES.date	2013-12-05
GENES.description	evidence-based annotation of the human genome (GRCh37), version 19 (Ensembl 74)
GENES.format	gtf
GENES.name	GENCODE V19 annotations
GENES.provider	GENCODE
PATIENTS.biospecimen_aliquot|bcr_aliquot_barcode	tcga-36-2552-01a-01d-1526-09
PATIENTS.biospecimen_aliquot|bcr_aliquot_uuid	e97a1340-6d99-400d-80c5-141096e642ac
PATIENTS.biospecimen_aliquot|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.biospecimen_aliquot|bcr_sample_barcode	tcga-36-2552-01a
PATIENTS.biospecimen_aliquot|biospecimen_barcode_bottom	1049949147
PATIENTS.biospecimen_aliquot|center_id	09
PATIENTS.biospecimen_aliquot|concentration	0.05
PATIENTS.biospecimen_aliquot|date_of_shipment	2011-02-02
PATIENTS.biospecimen_aliquot|is_derived_from_ffpe	no
PATIENTS.biospecimen_aliquot|plate_column	5
PATIENTS.biospecimen_aliquot|plate_id	1526
PATIENTS.biospecimen_aliquot|plate_row	e
PATIENTS.biospecimen_aliquot|quantity	3.00
PATIENTS.biospecimen_aliquot|source_center	22
PATIENTS.biospecimen_aliquot|volume	60.00
PATIENTS.biospecimen_analyte|a260_a280_ratio	1.90
PATIENTS.biospecimen_analyte|analyte_type	dna
PATIENTS.biospecimen_analyte|analyte_type_id	d
PATIENTS.biospecimen_analyte|bcr_analyte_barcode	tcga-36-2552-01a-01d
PATIENTS.biospecimen_analyte|bcr_analyte_uuid	9d466fa7-9529-4b30-968b-34ba0ebac8b8
PATIENTS.biospecimen_analyte|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.biospecimen_analyte|bcr_sample_barcode	tcga-36-2552-01a
PATIENTS.biospecimen_analyte|concentration	0.16
PATIENTS.biospecimen_analyte|gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
PATIENTS.biospecimen_analyte|is_derived_from_ffpe	no
PATIENTS.biospecimen_analyte|normal_tumor_genotype_match	yes
PATIENTS.biospecimen_analyte|pcr_amplification_successful	yes
PATIENTS.biospecimen_analyte|spectrophotometer_method	uv spec
PATIENTS.biospecimen_normal_control|bcr_patient_barcode	tcga-36-2552
PATIENTS.biospecimen_normal_control|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.biospecimen_portion|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.biospecimen_portion|bcr_portion_barcode	tcga-36-2552-01a-01
PATIENTS.biospecimen_portion|bcr_portion_uuid	e08c8201-0eca-473c-974b-cd6997895403
PATIENTS.biospecimen_portion|bcr_sample_barcode	tcga-36-2552-01a
PATIENTS.biospecimen_portion|date_of_creation	2010-03-01
PATIENTS.biospecimen_portion|is_ffpe	no
PATIENTS.biospecimen_portion|portion_number	01
PATIENTS.biospecimen_portion|weight	150.00
PATIENTS.biospecimen_protocol|bcr_analyte_barcode	tcga-36-2552-01a-01d
PATIENTS.biospecimen_protocol|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.biospecimen_protocol|bcr_sample_barcode	tcga-36-2552-01a
PATIENTS.biospecimen_protocol|experimental_protocol_type	adna preparation type
PATIENTS.biospecimen_sample|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.biospecimen_sample|bcr_sample_barcode	tcga-36-2552-01a
PATIENTS.biospecimen_sample|bcr_sample_uuid	55ca2556-a159-494a-85b9-b2932d5e1170
PATIENTS.biospecimen_sample|intermediate_dimension	0.8
PATIENTS.biospecimen_sample|is_ffpe	no
PATIENTS.biospecimen_sample|longest_dimension	1.3
PATIENTS.biospecimen_sample|pathology_report_file_name	tcga-36-2552.9504a356-0742-44f1-a218-62b769e64a33.pdf
PATIENTS.biospecimen_sample|pathology_report_uuid	9504a356-0742-44f1-a218-62b769e64a33
PATIENTS.biospecimen_sample|sample_type	primary tumor
PATIENTS.biospecimen_sample|sample_type_id	01
PATIENTS.biospecimen_sample|shortest_dimension	0.8
PATIENTS.biospecimen_sample|vial_number	a
PATIENTS.biospecimen_shipment_portion|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.biospecimen_shipment_portion|bcr_sample_barcode	tcga-36-2552-01a
PATIENTS.biospecimen_shipment_portion|bcr_shipment_portion_uuid	984b6351-1d3e-4ef1-99c4-d99895a3a49b
PATIENTS.biospecimen_shipment_portion|center_id	20
PATIENTS.biospecimen_shipment_portion|is_ffpe	no
PATIENTS.biospecimen_shipment_portion|plate_id	1561
PATIENTS.biospecimen_shipment_portion|portion_number	21
PATIENTS.biospecimen_shipment_portion|shipment_portion_bcr_aliquot_barcode	tcga-36-2552-01a-21-1561-20
PATIENTS.biospecimen_shipment_portion|shipment_portion_day_of_shipment	14
PATIENTS.biospecimen_shipment_portion|shipment_portion_month_of_shipment	2
PATIENTS.biospecimen_shipment_portion|shipment_portion_year_of_shipment	2011
PATIENTS.biospecimen_slide|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.biospecimen_slide|bcr_sample_barcode	tcga-36-2552-01a
PATIENTS.biospecimen_slide|bcr_slide_barcode	tcga-36-2552-01a-01-bs1
PATIENTS.biospecimen_slide|bcr_slide_uuid	b3c96dcc-504a-480c-87b3-9c88b0ea8c33
PATIENTS.biospecimen_slide|image_file_name	tcga-36-2552-01a-01-bs1.b3c96dcc-504a-480c-87b3-9c88b0ea8c33.svs
PATIENTS.biospecimen_slide|is_derived_from_ffpe	no
PATIENTS.biospecimen_slide|percent_necrosis	8
PATIENTS.biospecimen_slide|percent_normal_cells	0
PATIENTS.biospecimen_slide|percent_stromal_cells	20
PATIENTS.biospecimen_slide|percent_tumor_cells	72
PATIENTS.biospecimen_slide|percent_tumor_nuclei	80
PATIENTS.biospecimen_slide|section_location	bottom
PATIENTS.biospecimen_tumor_sample|bcr_patient_barcode	tcga-36-2552
PATIENTS.biospecimen_tumor_sample|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.clinical_drug|bcr_drug_barcode	tcga-36-2552-d27978
PATIENTS.clinical_drug|bcr_drug_uuid	8a05a1cd-08bc-4e8a-b376-7580f51e54b5
PATIENTS.clinical_drug|bcr_patient_barcode	tcga-36-2552
PATIENTS.clinical_drug|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.clinical_drug|form_completion_date	2010-8-18
PATIENTS.clinical_drug|pharma_adjuvant_cycles_count	06
PATIENTS.clinical_drug|pharmaceutical_therapy_drug_name	paclitaxel
PATIENTS.clinical_drug|pharmaceutical_therapy_type	chemotherapy
PATIENTS.clinical_drug|pharmaceutical_tx_dose_units	mg
PATIENTS.clinical_drug|pharmaceutical_tx_ended_days_to	121
PATIENTS.clinical_drug|pharmaceutical_tx_ongoing_indicator	no
PATIENTS.clinical_drug|pharmaceutical_tx_started_days_to	15
PATIENTS.clinical_drug|pharmaceutical_tx_total_dose_units	mg
PATIENTS.clinical_drug|prescribed_dose	241
PATIENTS.clinical_drug|route_of_administration	iv
PATIENTS.clinical_drug|therapy_regimen	adjuvant
PATIENTS.clinical_drug|total_dose	1449.5
PATIENTS.clinical_follow_up|bcr_followup_barcode	tcga-36-2552-f27976
PATIENTS.clinical_follow_up|bcr_followup_uuid	f0f073e9-431f-4e1b-bcf4-92efb3848872
PATIENTS.clinical_follow_up|bcr_patient_barcode	tcga-36-2552
PATIENTS.clinical_follow_up|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.clinical_follow_up|form_completion_date	2010-8-18
PATIENTS.clinical_follow_up|last_contact_days_to	349
PATIENTS.clinical_follow_up|pharmaceutical_tx_adjuvant	yes
PATIENTS.clinical_follow_up|radiation_treatment_adjuvant	no
PATIENTS.clinical_follow_up|tumor_status	tumor free
PATIENTS.clinical_follow_up|vital_status	alive
PATIENTS.clinical_patient|age_at_initial_pathologic_diagnosis	64
PATIENTS.clinical_patient|anatomic_neoplasm_subdivision	bilateral
PATIENTS.clinical_patient|bcr_patient_barcode	tcga-36-2552
PATIENTS.clinical_patient|bcr_patient_uuid	2d8b42fb-b12c-454e-a5a5-22c91913386f
PATIENTS.clinical_patient|birth_days_to	-23379
PATIENTS.clinical_patient|clinical_stage	stage iic
PATIENTS.clinical_patient|days_to_initial_pathologic_diagnosis	0
PATIENTS.clinical_patient|form_completion_date	2010-8-18
PATIENTS.clinical_patient|gender	female
PATIENTS.clinical_patient|histological_type	serous cystadenocarcinoma
PATIENTS.clinical_patient|history_neoadjuvant_treatment	no
PATIENTS.clinical_patient|icd_10	c56.9
PATIENTS.clinical_patient|icd_o_3_histology	8441/3
PATIENTS.clinical_patient|icd_o_3_site	c56.9
PATIENTS.clinical_patient|informed_consent_verified	yes
PATIENTS.clinical_patient|initial_pathologic_dx_year	2009
PATIENTS.clinical_patient|last_contact_days_to	349
PATIENTS.clinical_patient|method_initial_path_dx	tumor resection
PATIENTS.clinical_patient|patient_id	2552
PATIENTS.clinical_patient|residual_disease_largest_nodule	no macroscopic disease
PATIENTS.clinical_patient|residual_tumor	r0
PATIENTS.clinical_patient|tissue_source_site	36
PATIENTS.clinical_patient|tumor_grade	g3
PATIENTS.clinical_patient|tumor_status	tumor free
PATIENTS.clinical_patient|tumor_tissue_site	ovary
PATIENTS.clinical_patient|vital_status	alive
PATIENTS.manually_curated|center	genome.wustl.edu
PATIENTS.manually_curated|dataType	dnaseq
PATIENTS.manually_curated|exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/ov/dnaseq/TCGA-36-2552-01A-01D-1526-09.bed
PATIENTS.manually_curated|exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/ov/dnaseq/TCGA-36-2552-01A-01D-1526-09.bed.meta
PATIENTS.manually_curated|id	tcga-36-2552-01a-01d-1526-09
PATIENTS.manually_curated|md5sum	cb736b2672614ff97c0c19af53e07c86
PATIENTS.manually_curated|ncbi_build	36
PATIENTS.manually_curated|seqPlatform	illumina_ga2
PATIENTS.manually_curated|sequence_source	capture
PATIENTS.manually_curated|sequencer	illumina gaiix
PATIENTS.manually_curated|tissue_status	tumoral
PATIENTS.manually_curated|tumor_description	ovarian serous cystadenocarcinoma
PATIENTS.manually_curated|tumor_sample_uuid	e97a1340-6d99-400d-80c5-141096e642ac
PATIENTS.manually_curated|tumor_tag	ov
